Drug Chatter -- Tracking biopharma stock chatter

Profile for Epizyme, Inc. (EPZM)

« Back to company index

EPZM Chatter Timeline

Stock Ticker for EPZM

Most Active Tweeters for EPZM

UserTweets
@WKRBNews 10
@dakotafinancial 7
@TickerReport 6
@TheMarketsDaily 5
@chaffeybreeze 5

Recent Tweets for EPZM

Briefingcom @Briefingcom
$EPZM: Epizyme announces that the National Cancer Institute initiated its NCI-COG Pediatric MATCH study, which... https://t.co/RKa7ABpW7P
July 24th 2017, 6:07pm
srqstockpicker @srqstockpicker
RT @GNWLive: Epizyme Announces Tazemetostat to be Evaluated in NCI’s Recently Initiated NCI-COG Pediatric MATCH Trial $EPZM https://t.co/yJ…
July 24th 2017, 4:07pm
newswithvalue @newswithvalue
$EPZM: Epizyme Announces Tazemetostat to be Evaluated in NCI’s …: https://t.co/h1Ux26347N
July 24th 2017, 4:07pm
stockboardinc @stockboardinc
$EPZM Epizyme Announces Tazemetostat to be Evaluated in NCI’s Recently Initiated NCI-COG Pediatric MATCH... - https://t.co/HjO695Hnhe
July 24th 2017, 4:07pm
stocknewsdotcom @stocknewsdotcom
$EPZM Announces that the NCI has initiated its NCI-COG Pediatric MATCH study, which includes a phase 2 evaluation … https://t.co/7u9pZGNNI0
July 24th 2017, 4:07pm
YoungChris27040 @YoungChris27040
RT @odibro: $EPZM Announces Tazemetostat to be Evaluated in NCI’s Recently Initiated NCI-COG Pediatric MATCH Trial https://t.co/IRbGBW8jKc
July 24th 2017, 4:07pm
odibro @odibro
$EPZM Announces Tazemetostat to be Evaluated in NCI’s Recently Initiated NCI-COG Pediatric MATCH Trial https://t.co/IRbGBW8jKc
July 24th 2017, 4:07pm
GNWLive @GNWLive
Epizyme Announces Tazemetostat to be Evaluated in NCI’s Recently Initiated NCI-COG Pediatric MATCH Trial $EPZM https://t.co/yJfHwnmO0V
July 24th 2017, 4:07pm
dailypoliticaln @dailypoliticaln
Epizyme, Inc. $EPZM Shares Bought by Principal Financial Group Inc. https://t.co/SpCZAjXIax
July 24th 2017, 8:07am
midetimes @midetimes
Epizyme, Inc. $EPZM Shares Bought by Principal Financial Group Inc. https://t.co/vWCQlbbjrr
July 24th 2017, 8:07am
TheMarketsDaily @TheMarketsDaily
Principal Financial Group Inc. Increases Position in Epizyme, Inc. $EPZM https://t.co/smjHn5h17W
July 24th 2017, 8:07am
intercooleronli @intercooleronli
Epizyme, Inc. $EPZM Downgraded by BidaskClub https://t.co/Ec8orV99DK
July 23rd 2017, 5:07pm
WKRBNews @WKRBNews
Epizyme, Inc. $EPZM Lowered to “Sell” at BidaskClub https://t.co/pKoiY2O42N
July 23rd 2017, 11:07am
WKRBNews @WKRBNews
Epizyme, Inc. $EPZM Lowered to “Sell” at BidaskClub https://t.co/ac42P7M8CJ
July 23rd 2017, 11:07am
dailymailtimes @dailymailtimes
Epizyme, Inc. $EPZM Cut to Sell at BidaskClub https://t.co/JhbFCvJ3M5
July 22nd 2017, 3:07pm
WatchlistN @WatchlistN
Epizyme, Inc. $EPZM Upgraded to “Buy” at Zacks Investment Research https://t.co/Hmu71sOV1W
July 22nd 2017, 12:07pm
WKRBNews @WKRBNews
Epizyme, Inc. $EPZM Upgraded to “Buy” at Zacks Investment Research https://t.co/meQPe7aj2Z
July 22nd 2017, 11:07am
WKRBNews @WKRBNews
Epizyme, Inc. $EPZM Upgraded to “Buy” at Zacks Investment Research https://t.co/m6PJE5vUDt
July 22nd 2017, 11:07am
dakotafinancial @dakotafinancial
Epizyme, Inc. $EPZM Upgraded at Zacks Investment Research https://t.co/J9ZVWpU5eL
July 21st 2017, 4:07pm
SPNewsAnalysis @SPNewsAnalysis
Epizyme, Inc. $EPZM Downgraded to Sell at BidaskClub https://t.co/jCOyfTkOtl
July 21st 2017, 3:07pm
storminvestor @storminvestor
Epizyme, Inc. $EPZM Downgraded to Sell at BidaskClub https://t.co/TKUXX8aGYa
July 21st 2017, 3:07pm
WatchlistN @WatchlistN
Epizyme, Inc. $EPZM Stock Rating Lowered by Zacks Investment Research https://t.co/gKz03VT6is
July 21st 2017, 7:07am
dakotafinancial @dakotafinancial
Epizyme, Inc. $EPZM Cut to “Sell” at BidaskClub https://t.co/yGrqvOM1Wy
July 20th 2017, 8:07pm
chaffeybreeze @chaffeybreeze
Epizyme, Inc. $EPZM Downgraded by BidaskClub to “Sell” https://t.co/tZhD2zwYjk
July 20th 2017, 7:07pm
TranscriptDaily @TranscriptDaily
Epizyme, Inc. $EPZM Upgraded to “Buy” at Zacks Investment Research https://t.co/QfBrh6FGEM
July 20th 2017, 6:07pm
SleekMoneycom @SleekMoneycom
Epizyme $EPZM – Investment Analysts’ Recent Ratings Updates https://t.co/AT9rGb4jmc
July 20th 2017, 4:07pm
tymorapro @tymorapro
$EPZM: At/Below 200DaySMA VWAP[-13.31]:23d, lm:-3, News[Dngrd], 0NearLo, tf:0000011, ch:-4.4%, medFlt:36M, HiPctSht[14%:9d],
July 20th 2017, 1:07pm
intercooleronli @intercooleronli
Epizyme $EPZM – Investment Analysts’ Recent Ratings Updates https://t.co/2LTtlMzhO1
July 20th 2017, 1:07pm
dailymailtimes @dailymailtimes
Epizyme, Inc. $EPZM Cut to Sell at BidaskClub https://t.co/jmtxMWqfET
July 19th 2017, 7:07pm
SPNewsAnalysis @SPNewsAnalysis
Epizyme, Inc. $EPZM Upgraded to “Buy” at Zacks Investment Research https://t.co/nVrVWyGwHB
July 19th 2017, 1:07pm
TickerReport @TickerReport
Epizyme, Inc. $EPZM Upgraded to “Buy” at Zacks Investment Research https://t.co/iPHVIChfq1
July 19th 2017, 1:07pm
TickerReport @TickerReport
Epizyme, Inc. $EPZM Upgraded to “Buy” at Zacks Investment Research https://t.co/LNmqwL1stH
July 19th 2017, 1:07pm
emq_news @emq_news
Epizyme, Inc. $EPZM Upgraded to “Buy” at Zacks Investment Research https://t.co/OCPb1mMcdP
July 19th 2017, 1:07pm
dakotafinancial @dakotafinancial
Epizyme, Inc. $EPZM Downgraded to “Hold” at Zacks Investment Research https://t.co/4lk8Kyws6l
July 19th 2017, 12:07pm
emq_news @emq_news
Epizyme, Inc. $EPZM Stock Rating Lowered by Zacks Investment Research https://t.co/K0cv82rRMF
July 19th 2017, 8:07am
intercooleronli @intercooleronli
Epizyme, Inc. $EPZM Rating Increased to Buy at Zacks Investment Research https://t.co/h2mBEdZFyH
July 18th 2017, 8:07pm
ZolmaxNews @ZolmaxNews
Epizyme, Inc. $EPZM Upgraded by Zacks Investment Research to “Buy” https://t.co/EUn40lvWM1
July 18th 2017, 2:07pm
chaffeybreeze @chaffeybreeze
Epizyme, Inc. $EPZM Upgraded by Zacks Investment Research to “Buy” https://t.co/tCoecDRbre
July 18th 2017, 2:07pm
IRAMarketReport @IRAMarketReport
Epizyme, Inc. $EPZM Upgraded by Zacks Investment Research to “Buy” https://t.co/hBfO2Hwe2p
July 18th 2017, 1:07pm
RatingsNetwork @RatingsNetwork
Epizyme upgraded by Zacks Investment Research to buy. $16.00 PT. https://t.co/y6e0LJiZz7 $EPZM #EPZM
July 18th 2017, 1:07pm
deepxdive @deepxdive
$EPZM Epizyme, Inc. breached its 50 day moving average in a Bearish Manner EPZM-US July 18, 2017… https://t.co/fVjD3J7JKB
July 18th 2017, 9:07am
intercooleronli @intercooleronli
Zacks Investment Research Lowers Epizyme, Inc. $EPZM to Hold https://t.co/ODpo8Ee9sL
July 17th 2017, 3:07pm
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Downgrades Epizyme, Inc. $EPZM to Hold https://t.co/NvqmVYsOjb
July 17th 2017, 2:07pm
RatingsNetwork @RatingsNetwork
Epizyme downgraded by Zacks Investment Research to hold. https://t.co/JulEr8GDcN $EPZM #EPZM
July 17th 2017, 2:07pm
dakotafinancial @dakotafinancial
American International Group Inc. Has $425,000 Position in Epizyme, Inc. $EPZM https://t.co/VEJyhR6Sf7
July 16th 2017, 8:07am
emq_news @emq_news
American International Group Inc. Has $425,000 Position in Epizyme, Inc. $EPZM https://t.co/abCPOwAraL
July 16th 2017, 5:07am
TickerReport @TickerReport
American International Group Inc. Has $425,000 Position in Epizyme, Inc. $EPZM https://t.co/qzZtcCwsBo
July 16th 2017, 5:07am
TickerReport @TickerReport
American International Group Inc. Has $425,000 Position in Epizyme, Inc. $EPZM https://t.co/wEiiBaKAW6
July 16th 2017, 5:07am
TheMarketsDaily @TheMarketsDaily
Epizyme, Inc. $EPZM Given a $26.00 Price Target by Oppenheimer Holdings, Inc. Analysts https://t.co/UTkrLEAH3d
July 15th 2017, 4:07pm
TranscriptDaily @TranscriptDaily
Epizyme, Inc. $EPZM Position Cut by SG Americas Securities LLC https://t.co/DxBtLx6Wj8
July 15th 2017, 9:07am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.